What is Syntr Health Technologies?
Founded in 2018 by a team of specialized engineers, Syntr Health Technologies operates at the intersection of regenerative medicine and surgical automation. The company is currently headquartered at University Lab Partners in Orange County, a strategic location that facilitates access to top-tier wet lab infrastructure. Their core mission centers on the development of a specialized device designed to streamline the processing of adipose tissue directly at the point of care. By reducing the complexity and time associated with traditional tissue preparation, Syntr aims to improve patient recovery outcomes and enhance the overall quality of life for surgical candidates. The company's trajectory, bolstered by early-stage NIH SBIR support, positions it as a formidable player in the medical technology sector, specifically targeting the growing demand for efficient, automated surgical tools.
How much funding has Syntr Health Technologies raised?
Syntr Health Technologies has raised a total of $2.2M across 1 funding round:
Angel/Seed
$2.2M
Angel/Seed (2021): $2.2M, investors not publicly disclosed
Key Investors in Syntr Health Technologies
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Syntr Health Technologies?
With the infusion of $2.2M, Syntr Health Technologies is poised to transition from its initial research and development phase into a more aggressive commercialization strategy. The company will likely prioritize clinical validation and regulatory milestones to solidify its market position. Future growth initiatives will focus on scaling manufacturing capabilities and expanding the clinical utility of its adipose processing platform. As the firm matures, it will likely seek further strategic partnerships to integrate its technology into broader surgical workflows, aiming to establish a new standard of care in regenerative surgical procedures. The focus remains on achieving market leadership through technical precision and clinical efficacy.
See full Syntr Health Technologies company page
